Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.
Press releases published on July 4, 2025
Absolute Digital Media Launches Dubai HQ as Part of Global Expansion
EIN Presswire
·
July 4, 2025
Award-winning UK agency Absolute Digital Media launches Dubai HQ to deliver high-impact SEO, PPC, and digital growth for ambitious UAE brands. DUBAI, UNITED ARAB EMIRATES, July 4, 2025 /EINPresswire.com/ -- Award-winning performance agency Absolute …
Aston VIP Streamlines Market Entry and Licensing for Global Firms Navigating Gulf Financial Regulations
EIN Presswire
·
July 4, 2025
Aston VIP guides global firms through UAE’s financial regulations, offering expert compliance and licensing support across DIFC, ADGM, and VARA DUBAI, DUBAI, UNITED ARAB EMIRATES, July 4, 2025 /EINPresswire.com/ -- Aston VIP Streamlines Market Entry and …
Medical Supplierz Introduces AI-Powered Search to Enhance B2B Buyer-Supplier Matching
EIN Presswire
·
July 4, 2025
KUWAIT, KUWAIT, July 4, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B marketplace for the medical equipment industry, has announced plans to launch an artificial intelligence (AI)-driven search tool aimed at optimizing how healthcare buyers …
Little Pepe Raises Over $3,500,000 as It Becomes Ethereum’s Hottest Meme Token of 2025
GlobeNewswire
·
July 4, 2025
DUBAI, United Arab Emirates, July 04, 2025 (GLOBE NEWSWIRE) -- Little Pepe has rapidly emerged as Ethereum’s hottest meme token of 2025, having raised over $3.5 million in its presale and currently in Stage 4 at a price of $0.0013. More than just a meme …
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
GlobeNewswire
·
July 4, 2025
Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with …